Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 12 May 2021 |
2 | Journal Copy | 19 Jul 2021 |
3 | TM-O(NOTICE OF OPPOSITION) | 18 Oct 2021 |
4 | Evidence Affidavit Under Rule 46 (TOP) | 30 Jan 2023 |
5 | Annexure -1 under rule 46 | 30 Jan 2023 |
1 | Opposition Notice | 12894262 | 5470961 | 27 Jan 2022 |
2 | Opposition Counter Statement | 14333980 | 5763234 | 14 Nov 2022 |
3 | Hearing Notice | 17565056 | 6594651 | 28 Feb 2024 |
The application for Molpivir was made on 12 May 2021.
The trademark applicant for Molpivir is SUN PHARMACEUTICAL INDUSTRIES.
Molpivir is applied in class(es) 5.
Application for Molpivir is on Opposed stage.
Application Id allotted to Molpivir is 4971391.
Molpivir filed with the Intellectual property office as a WORD.